Type 1 Diabetes Research
Research Funding Opportunities - Archives*
View current or upcoming research funding opportunities.
2008
Beta Cell Biology Consortium 2008 Pilot and Feasibility Programhttp://www.betacell.org/pilot
This Pilot and Feasibility Program will provide research support for a limited time (1-2 years) to enable eligible investigators to explore the feasibility of concepts related to the mission of the Beta Cell Biology Consortium (BCBC). Areas of research particularly relevant to the current effort of the consortium include, but are not limited to:
- production of human beta-cells for cell replacement strategies,
- beta-cell regeneration and regulation of beta-cell mass,
- small molecules or secreted factors controlling beta-cell fate or beta-cell regeneration, or
- non-invasive imaging of beta-cell mass in vivo.
Type 1 Diabetes Pathfinder Award (DP2)
RFA-DK-08-001
Release/Posted Date: November 26, 2007
Opening Date: March 10, 2008 (Earliest date an application may be submitted to Grants.gov)
Letters of Intent Receipt Date: March 13, 2008
Application Submission/Receipt Date: April 10, 2008
Frequently Asked Questions (FAQs) at: http://www2.niddk.nih.gov/Funding/FundingOpportunities/RFA/RFA_T1D_Pathfinder_Award.htm
2007
Limited Competition: The Environmental Determinants of Diabetes in the Youth (TEDDY) study ( U01) RFA-DK-07-500Release Date: June 21, 2007
Letters of Intent Receipt Date: July 27, 2007
Application Receipt Date: August 29, 2007
2006
High-Density Genotyping of Diabetes and Diabetic Complications Sample Collections (R01)RFA-DK-06-005
Release Date: December 28, 2005
Application Receipt Date: April 12, 2006
Biomarker Development for Diabetic Complications (R21)
RFA-DK-06-004
Release Date: April 19, 2006
Letters of Intent Receipt Date: November 13, 2006
Application Submission/Receipt Date: December 12, 2006
Cooperative Multicenter Diabetes Research Network for Hypoglycemia Prevention (U10)
RFA-HD-06-020
Release Date: October 10, 2006
Letters of Intent Receipt Date: October 23, 2006
Application Receipt Date: November 22, 2006
Non-Human Primate Islet/Kidney Transplantation Tolerance (U01, U19)
RFA-AI-06-018
Release Date: May 10, 2006
Letters of Intent Receipt Date: August 22, 2006
Application Receipt Date: September 22, 2006
Biomarkers of Autoimmunity in Type 1 Diabetes (R21)
RFA-DK-06-002
Release Date: December 28, 2005
Letters of Intent Receipt Date: March 14, 2006
Application Receipt Date: April 12, 2006
Toward Imaging the Pancreatic Beta Cell in People (R01)
RFA-DK-06-003
Release Date: December 13, 2005
Letters of Intent Receipt Date: March 14, 2006
Application Receipt Date: April 12, 2006
TOP
2005
Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) and its Complications (SBIR [R43/R44])RFA-DK-05-016
Release Date: October 18, 2005
Letters of Intent Receipt Date: February 15, 2006
Application Receipt Date: March 15, 2006
Small Business Technology Transfer to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) and its Complications (STTR [R41/R42])
RFA-DK-05-015
Release Date: October 18, 2005
Letters of Intent Receipt Date: February 15, 2006
Application Receipt Dates: March 15, 2006
Human Pancreatic Islet Cell Resources (ICRs)
RFA-RR-05-003
Release Date: July 18, 2005
Letters of Intent Receipt Date: December 6, 2005
Application Receipt Date: January 6, 2006
Animal Models of Diabetic Complications Consortium
RFA-DK-05-011
Release Date: August 17, 2005
Letters of Intent Receipt Date: October 21, 2005
Application Receipt Date: November 18, 2005
Mouse Metabolic Phenotyping Centers Consortium
RFA-DK-05-008
Release Date: June 8, 2005
Letters of Intent Receipt Date: October 14, 2005
Application Receipt Dates: November 16, 2005
Administrative Supplements for a Drug Screening Program for Diabetic Complications
NOT-DK-05-017
Release Date: August 17, 2005
Request Receipt Date: December 1, 2005
Cooperative Study Group for Autoimmune Disease Prevention
RFA-AI-05-026
Release Date: May 12, 2005
Letters of Intent Receipt Date: September 12, 2005
Application Receipt Dates: October 12, 2005
Incidence, Natural History, and Quality of Life of Diabetes in Youth
RFA-DP-05-069
Release Date: May 11, 2005
Letters of Intent Receipt Date: May 25, 2005
Application Receipt Date: June 24, 2005
Beta Cell Regeneration for Diabetes Therapy
RFA-DK-05-007
Release Date: March 1, 2005
Letter of Intent: May 22, 2005
Application Receipt Date: June 22, 2005
Preclinical Study of Efficacy in Animal Models of Diabetic Complications
NIH-NIDDK-O5-04
NOT-DK-05-008
Preclinical Study of Efficacy in Animal Models of Type 1 Diabetes
NIH-NIDDK-O5-05
NOT-DK-05-009
TOP
2004
Collaborative Studies on Angiogenesis and Diabetic ComplicationsRFA-DK-04-022 (also see NOT-DK-05-003).
Release Date: November 3, 2004
Letter of Intent: February 17, 2005
Application Receipt Date: March 17, 2005
Immunobiology of Xenotransplantation
RFA-AI-04-042 (also see NOT-AI-04-054)
Release Date: August 6, 2004
Letter of Intent: October 22, 2004
Application Receipt Date: November 22, 2004
Beta Cell Biology Consortium (U19)
RFA-DK-04-017 (also see NOT-DK-04-016)
Release Date: June 21, 2004
Letter of Intent: October 19, 2004
Application Receipt Date: November 19, 2004
Beta Cell Biology Consortium (U01)
RFA-DK-04-018 (also see NOT-DK-04-016)
Release Date: June 21, 2004
Letter of Intent: October 19, 2004
Application Receipt Date: November 19, 2004
Cooperative Clinical Islet Transplantation Consortia: Data Coordinating Center
RFA-DK-04-004
Release Date: December 5, 2003
Letter of Intent: March 16, 2004
Application Receipt Date: April 13, 2004
Cooperative Clinical Islet Transplantation Consortia: Clinical Centers
RFA-DK-04-005
Release Date: December 5, 2003
Letter of Intent: March 16, 2004
Application Receipt Date: April 13, 2004
Progression of Cardiovascular Disease in Type 1 Diabetes
RFA-HL-04-013
Release Date: December 4, 2003
Letter of Intent: February 24, 2004
Application Receipt Date: March 24, 2004
2003
Bench to Bedside Research on Type 1 Diabetes and Its Complications
RFA: RFA-DK-03-019
Release Date: August 14, 2003
Letter of Intent: January 20, 2004
Application Receipt Date: February 20, 2004
Bench to Bedside Research on Type 1 Diabetes and its Complications
RFA: RFA-DK-03-001
Release Date: August 30, 2002
Letter of Intent Receipt Date: January 29, 2003
Application Receipt Date: February 26, 2003
Hypoglycemia in Patients with Type 1 Diabetes
RFA: RFA-DK-03-017
Release Date: August 14, 2003
Letter of Intent: January 20, 2004
Application Receipt Date: February 20, 2004
RFA: RFA-DK-03-015
Release Date: June 26, 2003
Letter of Intent: October 16, 2003
Application Receipt Date: November 13, 2003
Pilot and Feasibility Program in Human Islet Biology
RFA: RFA-DK-03-021
Release Date: July 14, 2003
Letter of Intent: October 20, 2003 and June 20, 2004
Application Receipt Date: November 20, 2003 and July 20, 2004
Proteomics and Metabolomics in Type 1 Diabetes and Its Complications
RFA-DK-03-024
Release Date: October 24, 2003
Letter of Intent: February 18, 2004
Application Receipt Date: March 18, 2004
Seeding Collaborative Research in Beta Cell Biology (SCRBCB)
www.betacell.org/php/highlight19.php
Release Date: May 29, 2003
Application Receipt Date: October 1, 2003
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) RFA in Type 1 Diabetes and Its Complications
RFA: RFA-DK-03-020
Release Date: August 28, 2003
Letter of Intent: January 19, 2004
Application Receipt Date: February 19, 2004
2002
Bench to Bedside Research on Type 1 Diabetes and its Complications
RFA: RFA-DK-02-022
Release Date: October 11, 2001
Letter of Intent: February 14, 2002
Application Receipt Date: March 14, 2002
Comprehensive Programs in Beta Cell Biology
RFA: RFA-DK-02-014
Release Date: August 14, 2001
Letter of Intent: February 13, 2002
Application Receipt Date: March 13, 2002
Bioinformatics Integration Support Contract
RFP: RFP-NIH-NIAID-DAIT-02-06
Release Date: November 27, 2001
Application Receipt Date: February 15, 2002
Consortium for Identification of Environmental Triggers of Type 1 Diabetes
RFA-DK-02-029
Release Date: January 22, 2002
Letter of Intent: March 5, 2002
Application Receipt Date: April 15, 2002
Data and Biosample Repository
RFP-DK-02-04
Effects of Hypoglycemia on Neuronal and Glial Cell Function
RFA: RFA-NS-02-008
Release Date: August 7, 2001
Letter of Intent: February 15, 2002
Application Receipt Date: March 15, 2002
Feasibility Projects to test Strategies for Preventing or Slowing the Progression of Diabetic Nephropathy
RFA: RFA-DK-02-025
Release Date: September 17, 2001
Letter of Intent: January 17, 2002
Application Receipt Date: February 14, 2002
Gene Transfer Approaches to Enhance Islet Transplantation
RFA: RFA-DK-02-020
Release Date: September 20, 2001
Letter of Intent: November 15, 2001
Application Receipt Date: December 12, 2001
Imaging Early Markers of Diabetic Microvascular Complications in Peripheral Tissue
RFA: RFA-DK-02-001
Release Date: November 26, 2001
Letter of Intent: February 15, 2002
Imaging Pancreatic Beta Cell Mass, Function, Engraftment or Inflammation
RFA: RFA-DK-02-002
Release Date: August 1, 2001
Letter of Intent: February 15, 2002
Application Receipt Date: March 15, 2002
Innovative Partnerships in Type 1 Diabetes Research
RFA: RFA-DK-02-023
Release Date: October 2, 2001
Letter of Intent: February 14, 2002
Application Receipt Date: March 14, 2002
Sensor Development and Validation
RFA: RFA-EB-02-002
Release Date: February 25, 2002
Letter of Intent: March 29, 2002
Application Receipt Date: April 24, 2002
Surrogate Endpoints for Diabetic Microvascular Complications
RFA: RFA-DK-02-016
Release Date: August 30, 2001
Letter of Intent: January 17, 2002
Application Receipt Date: February 14, 2002
Training Programs in Diabetes Research for Pediatric Endocrinologists
RFA: RFA-DK-02-024
Release Date: October 18, 2001
Letter of Intent: February 26, 2002
Application Receipt Date: March 26, 2002
2001
Beta Cell Biology Consortium
RFA: DK-01-014
Release Date: October 11, 2000
Letter of Intent: March 16, 2001
Application Receipt Date: April 17, 2001
Cooperative Multicenter Research Network to Test Glucose Sensors in Children With Type 1 Diabetes Mellitus
RFA: HD-01-009
Release Date: February 22, 2001
Letter of Intent: March 27, 2001
Application Receipt Date: May 11, 2001
Diabetic Macular Edema Clinical Trials Network
RFA: RFA-EY-01-001
Release Date: June 7, 2001
Application Receipt Date: October 26, 2001
Gene Therapy Approaches for Diabetes and Its Complications
RFA: DK-01-006
Release Date: August 30, 2000
Letter of Intent: October 16, 2000
Application Receipt Date: November 16, 2000
Human Pancreatic Islet Cell Resources (ICRs)
RFA: RR-01-002
Release Date: January 3, 2001
Letter of Intent: February 8, 2001
Application Receipt Date: March 21, 2001
Mouse Models of Diabetic Complications Consortium
RFA: DK-01-009
Release Date: October 31, 2000
Letter of Intent: February 28, 2001
Application Receipt Date: March 28, 2001
Non-Mouse Models of Diabetes Complications in Cardiovascular and Microvascular Diseases
RFA: HL-01-010
Release Date: November 20, 2000
Letter of Intent: February 26, 2001
Application Receipt Date: March 21, 2001
Non-Human Primate Immune Tolerance Cooperative Study Group
RFA: RFA-AI-01-006
Release Date: January 25, 2001
Letter of Intent: June 11, 2001
Application Receipt Date: July 17, 2001
Oral Microbiology/Immunology of Type 1 Diabetes
RFA: RFA-DE-01-001
Release Date: January 30, 2001
Letter of Intent: March 12, 2001
Application Receipt Date: April 12, 2001
Type 1 Diabetes Trialnet: Core Support Facilities
RFA: DK-01-004
Release Date: October 5, 2000
Letter of Intent Receipt Date: February 28, 2001
Application Receipt Date: March 29, 2001
Understanding Hypoglycemia Unawareness in Patients with Diabetes
Release Date: July 27, 2001
RFA: RFA-DK-01-031
Letter of Intent: October 14, 2001
Application Receipt Date: November 21, 2001
2000
Cooperative Study Group for Autoimmune Disease Prevention
RFA: RFA-AI-00-016
Release Date: September 7, 2000
Letter of Intent: December 15, 2000
Application Receipt Date: February 26, 2001
Innovative Grants on Immune Tolerance
RFA: AI-00-006
Release Date: February 9, 2000
Letter of Intent: August 1, 2000
Application Receipt Date: September 14, 2000
New Strategies for the Treatment of Type 1 Diabetes
RFA: RFA-DK-00-001
Release Date: September 30, 1999
Letter of Intent: March 14, 2000
Application Receipt Date: April 14, 2000
Neurobiology of Diabetic Complications
RFA: RFA-NS-00-002
Release Date: January 13, 2000
Letter of Intent: March 24, 2000
Application Receipt Date: April 25, 2000
1999
Collaborative Network for Clinical Research on Immune Tolerance
RFP: RFP-NIH-NIAID-DAIT-99-30
Release Date: January 15, 1999
Application Receipt Date: May 14, 1999
Functional Genomics of the Developing Endocrine Pancreas
RFA: RFA-DK-99-007
Release Date: December 4, 1998
Letter of Intent: February 10, 1999
Application Receipt Date: March 10, 1999
Neurological Complications of Diabetes
RFA: RFA-NS-99-005
Release Date: December 22, 1998
Letter of Intent: March 16, 1999
Application Receipt Date: April 27, 1999
Pilot Studies for New Therapies for Type 1 Diabetes and its Complications
RFA: RFA-DK-99-013
Release Date: January 8, 1999
Letter of Intent Receipt Date: March 1, 1999
Application Receipt Date: March 30, 1999
1998
Cellular and Molecular Approaches to Achieving Euglycemia
RFA: RFA-DK-98-007
Release Date: November 21, 1997
Letter of Intent: February 19, 1998
Application Receipt Date: March 19, 1998
Glucose Sensors in the Treatment of Diabetes
RFA: RFA-DK-98-008
Release Date: November 21, 1997
Letter of Intent: February 19, 1998
Application Receipt Date: March 19, 1998
Immunopathogenesis of Type 1 Diabetes
RFA: RFA-DK-98-010
Release Date: November 21, 1997
Letter of Intent: February 19, 1998
Application Receipt Date: March 19, 1998
Pathogenesis and Therapy of Complications of Diabetes
RFA: RFA-DK-98-009
Release Date: November 21, 1997
Letter of Intent: February 19, 1998
Application Receipt Date: March 19, 1998
*These opportunities are supported in whole or in part by the Special Statutory Funding Program for Type 1 Diabetes Research.
Last Updated: 10/08/2008
